Histone deacetylase inhibitors suppress IFNalpha-induced up-regulation of promyelocytic leukemia protein
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
17062732
DOI
10.1182/blood-2006-02-003418
PII: S0006-4971(20)41975-5
Knihovny.cz E-resources
- MeSH
- Transcriptional Activation drug effects MeSH
- Enzyme Inhibitors pharmacology MeSH
- Histone Deacetylase Inhibitors * MeSH
- Interferon-alpha pharmacology MeSH
- Nuclear Proteins genetics MeSH
- Cells, Cultured MeSH
- Humans MeSH
- Tumor Cells, Cultured MeSH
- Neoplasm Proteins genetics MeSH
- Tumor Suppressor Proteins genetics MeSH
- Promyelocytic Leukemia Protein MeSH
- RNA, Neoplasm analysis MeSH
- STAT2 Transcription Factor metabolism MeSH
- Transcription Factors genetics MeSH
- Up-Regulation drug effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Enzyme Inhibitors MeSH
- Histone Deacetylase Inhibitors * MeSH
- Interferon-alpha MeSH
- Nuclear Proteins MeSH
- Neoplasm Proteins MeSH
- Tumor Suppressor Proteins MeSH
- PML protein, human MeSH Browser
- Promyelocytic Leukemia Protein MeSH
- RNA, Neoplasm MeSH
- STAT2 Transcription Factor MeSH
- Transcription Factors MeSH
Promyelocytic leukemia nuclear bodies (PML NBs), the structural domains of the eukaryotic cell nucleus, play a role in cancer and apoptosis, and their involvement in antiviral mechanisms mediated by interferons (IFNs) is proposed. IFNs dramatically increase the transcription of the PML gene. In this study, we have shown that the response of 2 structural PML NB components, PML and Sp100, to interferon-alpha (IFNalpha) was suppressed in cells simultaneously treated with histone deacetylase (HDAC) inhibitors (trichostatin A, sodium butyrate, MS-275, SAHA, and valproic acid). Trichostatin A (TSA) blocked the increase of PML NB number and suppressed up-regulation of PML mRNA and protein levels in several human cell lines and in normal diploid skin fibroblasts. Moreover, IFNalpha induction of IRF-1 was also inhibited by TSA, although incompletely. Analysis of cellular fractions did not show any defects in cytoplasmic-nuclear transport of STAT2, a component of transcription factor ISGF3 responsible for IFNalpha/beta-dependent gene transcription. Moreover, chromatin immunoprecipitation showed that after IFNalpha stimulation STAT2 binds to ISRE element of PML promoter even in the presence of TSA and thus excluded STAT2-dependent mechanism of TSA effect. These results indicate that the action of histone deacetylases is necessary for the full transcriptional activation of IFNalpha-stimulated genes.
Blood. 2007 Jun 1;109(11):4606 PubMed
References provided by Crossref.org